Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathy. Article uri icon

Overview

abstract

  • SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction. Here we show that a particularly vulnerable population with neurologic manifestations of COVID-19 harbor an influx of inflammatory cytokines within the cerebrospinal fluid in the absence of viral neuro-invasion. The majority of these inflammatory mediators are driven by type 2 interferon and are known to induce neuronal injury in other disease models. Levels of matrix metalloproteinase-10 within the spinal fluid correlate with the degree of neurologic dysfunction. Furthermore, this neuroinflammatory process persists weeks following convalescence from the acute respiratory infection. These prolonged neurologic sequelae following a systemic cytokine release syndrome lead to long-term neurocognitive dysfunction with a wide range of phenotypes.

publication date

  • September 18, 2020

Identity

PubMed Central ID

  • PMC7523144

Digital Object Identifier (DOI)

  • 10.1101/2020.09.15.20195511

PubMed ID

  • 32995805